Nuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in mice

FEBS Journal

Volumn 280, Issue 15, 2013, Pages 3609-3620

  Lee, Candy S ^a   Ho, Daniel V ^a   Chan, Jefferson Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ER stress; Nrf1; proteasome; steatohepatitis; transcriptional regulation

Indexed keywords

PROTEASOME; TRANSCRIPTION FACTOR NRF1; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; GENE EXPRESSION REGULATION; GENE FUNCTION; HISTOLOGY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEASOME GENE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ER STRESS; NRF1; PROTEASOME; STEATOHEPATITIS; TRANSCRIPTIONAL REGULATION;

ANIMALS; BORONIC ACIDS; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; LIVER; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 1; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES;

MUS;

EID: 84880327440     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12350     Document Type: Article

References (52)

1. Hershko A, &, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67, 425-479.
2. Glickman MH, &, Ciechanover A, (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82, 373-428.
3. Silva GM, Netto LE, Simoes V, Santos LF, Gozzo FC, Demasi MA, Oliveira CL, Bicev RN, Klitzke CF, Sogayar MC, et al,. (2012) Redox control of 20S proteasome gating. Antioxid Redox Signal 16, 1183-1194.
4. Ciechanover A, (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17, 7151-7160.
5. Golab J, Bauer TM, Daniel V, &, Naujokat C, (2004) Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases. Clin Chim Acta 340, 27-40.
6. Petroski MD, (2008) The ubiquitin system, disease, and drug discovery. BMC Biochem 9, S7.
7. Ciechanover A, &, Brundin P, (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427-446.
8. McNaught KSP, Olanow CW, Halliwell B, Isacson O, &, Jenner P, (2001) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci 2, 589-594.
9. Banner BF, Savas L, Zivny J, Tortorelli K, &, Bonkovsky HL, (2000) Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis. Am J Clin Pathol 114, 860-866.
10. Takagi M, Yamauchi M, Takada K, &, Ohkawa K, (2002) Serum ubiquitin-protein conjugates in normal subjects and patients with alcoholic liver diseases: immunoaffinity isolation and electrophoretic mobility. Alcohol Clin Exp Res 26, 1692-1696.
11. Shirahashi H, Sakaida I, Terai S, Hironaka K, Kusano N, &, Okita K, (2002) Ubiquitin and hepatocellular carcinoma. Liver 22, 413-418.
12. French S, &, Bardag-Gorce F, (2005) Ubiquitin-proteasome pathway in the pathogenesis of liver disease. In Signaling Pathways in Liver Diseases (Dufour JF, Clavien PA, Trautwein C & Graf R, eds), pp. 377-389. Springer, Berlin.
13. Pickart CM, (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70, 503-533.
14. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, &, Huber R, (1997) Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386, 463-471.
15. Groll M, Bajorek M, Kohler A, Moroder L, Rubin DM, Huber R, Glickman MH, &, Finley D, (2000) A gated channel into the proteasome core particle. Nat Struct Mol Biol 7, 1062-1067.
16. Chan JY, Han XL, &, Kan YW, (1993) Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci USA 90, 11371-11375.
17. Johnsen O, Murphy P, Prydz H, &, Kolsto AB, (1998) Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res 26, 512-520.
18. Motohashi H, O'Connor T, Katsuoka F, Engel JD, &, Yamamoto M, (2002) Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294, 1-12.
19. Kwong M, Kan YW, &, Chan JY, (1999) The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts. J Biol Chem 274, 37491-37498.
20. Ohtsuji M, Katsuoka F, Kobayashi A, Aburatani H, Hayes JD, &, Yamamoto M, (2008) Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J Biol Chem 283, 33554-33562.
21. Venugopal R, &, Jaiswal AK, (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 93, 14960-14965.
22. Myhrstad MC, Husberg C, Murphy P, Nordstrom O, Blomhoff R, Moskaug JO, &, Kolsto AB, (2001) TCF11/Nrf1 overexpression increases the intracellular glutathione level and can transactivate the gamma-glutamylcysteine synthetase (GCS) heavy subunit promoter. Biochim Biophys Acta 1517, 212-219.
23. Biswas M, &, Chan JY, (2010) Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 244, 16-20.
24. Xing W, Singgih A, Kapoor A, Alarcon CM, Baylink DJ, &, Mohan S, (2007) Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. J Biol Chem 282, 22052-22061.
25. Narayanan K, Ramachandran A, Peterson MC, Hao J, Kolsto AB, Friedman AD, &, George A, (2004) The CCAAT enhancer-binding protein (C/EBP)beta and Nrf1 interact to regulate dentin sialophosphoprotein (DSPP) gene expression during odontoblast differentiation. J Biol Chem 279, 45423-45432.
26. Berg DT, Gupta A, Richardson MA, O'Brien LA, Calnek D, &, Grinnell BW, (2007) Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11. J Biol Chem 282, 36837-36844.
27. Lee CS, Lee C, Hu T, Nguyen JM, Zhang J, Martin MV, Vawter MP, Huang EJ, &, Chan JY, (2011) Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc Natl Acad Sci USA 108, 8408-8413.
28. Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY, &, Deshaies RJ, (2010) Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell 38, 17-28.
29. Xu Z, Chen L, Leung L, Yen TS, Lee C, &, Chan JY, (2005) Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci USA 102, 4120-4125.
30. Meiners S, Heyken D, Weller A, Ludwig A, Stangl K, Kloetzel PM, &, Kruger E, (2003) Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J Biol Chem 278, 21517-21525.
31. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Fanourakis G, Gu X, Bailey C, Joseph M, Libermann TA, Treon SP, et al,. (2002) Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc Natl Acad Sci USA 99, 14374-14379.
32. Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, &, Kong AN, (2006) Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett 243, 170-192.
33. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, &, Kensler TW, (2003) Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23, 8786-8794.
34. Szokalska A, Makowski M, Nowis D, Wilczynski GM, Kujawa M, Wojcik C, Mlynarczuk-Bialy I, Salwa P, Bil J, Janowska S, et al,. (2009) Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res 69, 4235-4243.
35. Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr, Lee KP, &, Boise LH, (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107, 4907-4916.
36. Nawrocki ST, Carew JS, Dunner K Jr, Boise LH, Chiao PJ, Huang P, Abbruzzese JL, &, McConkey DJ, (2005) Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res 65, 11510-11519.
37. Chauhan D, Singh A, Brahmandam M, Podar K, Hideshima T, Richardson P, Munshi N, Palladino MA, &, Anderson KC, (2008) Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma. Blood 111, 1654-1664.
38. Zhang K, Wang S, Malhotra J, Hassler JR, Back SH, Wang G, Chang L, Xu W, Miao H, Leonardi R, et al,. (2011) The unfolded protein response transducer IRE1alpha prevents ER stress-induced hepatic steatosis. EMBO J 30, 1357-1375.
39. Cinaroglu A, Gao C, Imrie D, &, Sadler KC, (2011) Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish. Hepatology 54, 495-508.
40. Rutkowski DT, Wu J, Back SH, Callaghan MU, Ferris SP, Iqbal J, Clark R, Miao H, Hassler JR, Fornek J, et al,. (2008) UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell 15, 829-840.
41. Jiang HY, Wek SA, McGrath BC, Lu D, Hai T, Harding HP, Wang X, Ron D, Cavener DR, &, Wek RC, (2004) Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 24, 1365-1377.
42. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, &, Ron D, (2004) CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18, 3066-3077.
43. Wek RC, &, Cavener DR, (2007) Translational control and the unfolded protein response. Antioxid Redox Signal 9, 2357-2371.
44. Vilatoba M, Eckstein C, Bilbao G, Smyth CA, Jenkins S, Thompson JA, Eckhoff DE, &, Contreras JL, (2005) Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery 138, 342-351.
45. Welch WJ, &, Brown CR, (1996) Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperon 1, 109-115.
46. Sykiotis GP, &, Bohmann D, (2010) Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal 3, re3.
47. Chan JY, Kwong M, Lu R, Chang J, Wang B, Yen TS, &, Kan YW, (1998) Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J 17, 1779-1787.
48. Zhang Y, Lucocq JM, &, Hayes JD, (2009) The Nrf1 CNC/bZIP protein is a nuclear envelope-bound transcription factor that is activated by t-butyl hydroquinone but not by endoplasmic reticulum stressors. Biochem J 418, 293-310.
49. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, &, Ron D, (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664-666.
50. Gentile CL, Frye MA, &, Pagliassotti MJ, (2011) Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. BioFactors 37, 8-16.
51. Luo R, Klumpp SA, Finegold MJ, &, Maity SN, (2011) Inactivation of CBF/NF-Y in postnatal liver causes hepatocellular degeneration, lipid deposition, and endoplasmic reticulum stress. Sci Rep 1, 136.
52. Hirotsu Y, Hataya N, Katsuoka F, &, Yamamoto M, (2012) NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the lipin1 and PGC-1beta genes. Mol Cell Biol 32, 2760-2770.